2009
DOI: 10.21101/cejph.a3483
|View full text |Cite
|
Sign up to set email alerts
|

The Trends and Risk Factors for Hepatitis B Occurrence in Estonia

Abstract: SUMMARYHepatitis B virus (HBV) infection is prevalent worldwide and is a significant cause of morbidity and mortality. This article describes the trend in HBV occurrence in Estonia from 1990 to 2005 in Estonia, with the aim of highlighting key determinants in transmission dynamics, risk groups, and possible implications for prevention and control.A marked increase in reported numbers of new HBV cases occurred in mid 1990s (reaching 39 per 100,000 population) and decline thereafter. We present data on HBV preva… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 29 publications
1
1
0
Order By: Relevance
“…The increase in the late 1990s was due to a nationwide outbreak of hepatitis A and hepatitis B among IDUs [ 10 , 14 ]. Similar outbreaks were observed in Finland, Sweden and the Baltic countries, mainly among groups of non-immune IDUs [ 14 , 15 ]. These outbreaks coincided with increased number of IDUs and reduced drug prices [ 10 , 14 , 16 ].…”
Section: Discussionsupporting
confidence: 69%
See 1 more Smart Citation
“…The increase in the late 1990s was due to a nationwide outbreak of hepatitis A and hepatitis B among IDUs [ 10 , 14 ]. Similar outbreaks were observed in Finland, Sweden and the Baltic countries, mainly among groups of non-immune IDUs [ 14 , 15 ]. These outbreaks coincided with increased number of IDUs and reduced drug prices [ 10 , 14 , 16 ].…”
Section: Discussionsupporting
confidence: 69%
“…Similar outbreaks were observed in Finland, Sweden and the Baltic countries, mainly among groups of non-immune IDUs [14,15]. These outbreaks coincided with increased number of IDUs and reduced drug prices [10,14,16].…”
Section: Discussionmentioning
confidence: 55%